References
- Bayry J, Thirion M, Misra N, . 2003. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Neurological Sciences 24:S217–S221.
- Breeze AC, Alexander PM, Murdoch EM, . 2007. Obstetric and neonatal outcomes in severe fetal ventriculomegaly. Prenatal Diagnosis 27:124–129.
- Clark DA, Coulam CB, Stricker RB. 2006. Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). Journal of Assisted Reproduction and Genetics 23:1–13.
- Dunn D, Wallon M, Peyron F, . 1999. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353: 1829–1833.
- Kennelly MM, Cooley SM, McParland PJ. 2009. Natural history of apparently isolated severe fetal ventriculomegaly: perinatal survival and neurodevelopmental outcome. Prenatal Diagnosis 29:1135–1140.
- Malinger G, Werner H, Rodriquez Leonel JC, . 2011. Prenatal brain imaging in congenital toxoplasmosis. Prenatal Diagnosis PMID:21706510 [Epub ahead of print].
- RCOG. 2011. Green Top Guideline No. 17. The investigation and treatment of couples with recurrent first trimester and second trimester miscarriage. London: Royal College of Obstetricians and Gynaecologists.